Skip to main content
Log in

Atorvastatin cost saving for preventing cardiovascular events

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Straka RJ, Mamdani M, Damen J, Kuntze CEE, Liu LZ, Botteman MF, Koren MJ.Economic impacts attributable to the early clinical benefit of atorvastatin therapy - a US managed care perspective. Current Medical Research and Opinion 23: 1517-1529, No. 7, Jul 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atorvastatin cost saving for preventing cardiovascular events. Pharmacoecon. Outcomes News 536, 4 (2007). https://doi.org/10.2165/00151234-200705360-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705360-00010

Keywords

Navigation